David Nathanson

De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.

Ivan Babic, Paul S Mischel, Harley I Kornblum, 2013, Cancer discovery.

Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.

Ivan Babic, Paul S Mischel, Timothy F Cloughesy, 2011, Cancer discovery.

Evaluation of the Genisys4, a Bench-Top Preclinical PET Scanner

Arion F. Chatziioannou, Magnus Dahlbom, Johannes Czernin, 2013, The Journal of Nuclear Medicine.

EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer.

Douglas L Black, Ivan Babic, Paul S Mischel, 2013, Cell metabolism.

A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens.

Hong Wu, Shuang Hou, Michael E Phelps, 2010, Cancer research.

Fast Metabolic Response to Drug Intervention Through Analysis on a Miniaturized, Highly Integrated Molecular Imaging System

Caius Radu, Michael E Phelps, Arion F Chatziioannou, 2013, The Journal of Nuclear Medicine.